Gall Matthew
Tango Therapeutics, Inc. · Chief Financial Officer
Gall Matthew is listed in public filings as officer: Chief Financial Officer. This Gall Matthew insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Tango Therapeutics, Inc. (TNGX), Kalaris Therapeutics Inc (KLRS), and iTeos Therapeutics, Inc. (ITOS). Investors use Gall Matthew's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $5.0M240k shares | Grant / ExerciseMay 1, 2026 | $5.0M240k shares | $20.98 | -- | |
| --40k shares | Grant / ExerciseMay 1, 2026 | Disclosure amount unavailable40k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $647k95k shares | Grant / ExerciseMar 19, 2026 | $647.0K95k shares | $6.81 | -- | |
| $1.2M235k shares | Grant / ExerciseNov 3, 2025 | $1.2M235k shares | $4.99 | -- | |
| $0252.1k shares | OtherAug 29, 2025 | $1.6M252.1k shares | $6.16 | -- | |
| $0135.9k shares | OtherAug 29, 2025 | $958.4K135.9k shares | $7.05 | -- | |
| $089.4k shares | OtherAug 29, 2025 | $898.5K89.4k shares | $10.05 | -- | |
| $1.0M145k shares | Grant / ExerciseMar 7, 2025 | $1.0M145k shares | $7.05 | -- | |
| --89.4k shares | Grant / ExerciseMar 7, 2025 | Disclosure amount unavailable24k shares | -- | -- | |
| $506k65.4k shares | BuyNov 19, 2024 | $38.6K5k shares | $7.73 | -- |